Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Aldiamed
2. Hydroxyethylcellulose
3. Hydroxyethylcellulose, Sodium Salt
4. Hydroxyl Ethyl Cellulose
5. Lacrigel
6. Minims Artificial Tears
7. Natrosol 250
1. Hetastarch
2. 9004-62-0
3. 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol
4. 2-hydroxyethyl Cellulose
5. Hydroxyethyl-cellulose
6. Schembl23306563
7. Dtxsid60873934
8. Ft-0627136
9. H11622
10. 2-hydroxyethyl Cellulose; Cellulose Hydroxyethyl Ether
11. 2-o-(2-hydroxyethyl)-4-o-methylhexopyranosyl-(1->4)-[4-o-methylhexopyranosyl-(1->6)]hexopyranosyl-(1->5)-2,6-anhydro-1-deoxyheptitol
Molecular Weight | 736.7 g/mol |
---|---|
Molecular Formula | C29H52O21 |
XLogP3 | -7.7 |
Hydrogen Bond Donor Count | 11 |
Hydrogen Bond Acceptor Count | 21 |
Rotatable Bond Count | 15 |
Exact Mass | 736.30010866 g/mol |
Monoisotopic Mass | 736.30010866 g/mol |
Topological Polar Surface Area | 315 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 999 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 20 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
87
PharmaCompass offers a list of Hetastarch API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hetastarch manufacturer or Hetastarch supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hetastarch manufacturer or Hetastarch supplier.
PharmaCompass also assists you with knowing the Hetastarch API Price utilized in the formulation of products. Hetastarch API Price is not always fixed or binding as the Hetastarch Price is obtained through a variety of data sources. The Hetastarch Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A hydroxyethylcellulose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of hydroxyethylcellulose, including repackagers and relabelers. The FDA regulates hydroxyethylcellulose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. hydroxyethylcellulose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A hydroxyethylcellulose supplier is an individual or a company that provides hydroxyethylcellulose active pharmaceutical ingredient (API) or hydroxyethylcellulose finished formulations upon request. The hydroxyethylcellulose suppliers may include hydroxyethylcellulose API manufacturers, exporters, distributors and traders.
click here to find a list of hydroxyethylcellulose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing hydroxyethylcellulose as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for hydroxyethylcellulose API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture hydroxyethylcellulose as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain hydroxyethylcellulose and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a hydroxyethylcellulose NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of hydroxyethylcellulose suppliers with NDC on PharmaCompass.
hydroxyethylcellulose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of hydroxyethylcellulose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right hydroxyethylcellulose GMP manufacturer or hydroxyethylcellulose GMP API supplier for your needs.
A hydroxyethylcellulose CoA (Certificate of Analysis) is a formal document that attests to hydroxyethylcellulose's compliance with hydroxyethylcellulose specifications and serves as a tool for batch-level quality control.
hydroxyethylcellulose CoA mostly includes findings from lab analyses of a specific batch. For each hydroxyethylcellulose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
hydroxyethylcellulose may be tested according to a variety of international standards, such as European Pharmacopoeia (hydroxyethylcellulose EP), hydroxyethylcellulose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (hydroxyethylcellulose USP).